Literature DB >> 19277693

An epidemiological approach for the estimation of disease onset in Central Europe in central and peripheral monogenic retinal dystrophies.

Elena Prokofyeva1, Robert Wilke, Gunnar Lotz, Eric Troeger, Torsten Strasser, Eberhart Zrenner.   

Abstract

PURPOSE: To study clinical patterns of disease onset in monogenic retinal dystrophies (MRD), using an epidemiological approach.
METHODS: Records of patients with MRD, seen at the University Eye Hospital Tuebingen from 1994 to 1999, were selected from a database and retrospectively reviewed. For analysis, patients were divided into 2 groups by predominant part of visual field (VF) involvement: group 1 (predominantly central involvement) included Stargardt disease (ST), macular dystrophy (MD), and central areolar choroidal dystrophy (CACD), and group 2 (predominantly peripheral involvement) included Bardet-Biedl syndrome (BBD), Usher syndrome (USH) I and II, and choroideremia (CHD). Age, sex, age of first diagnosis, age of visual acuity (VA) decrease and VF emergence, night blindness and photophobia onset, types of VF defects and age of its onset, color discrimination defects and best corrected VA were analyzed.
RESULTS: Records of 259 patients were studied. Men were more prevalent than women. Mean age of the patients was 47.2 (SD = 15.6) years old. Forty-five patients in the first group and 40 in the second were first diagnosed between 21 and 30 years of age. Ninety-four patients in the first group had VA decrease before 30 years of age; in the second group, 68 patients had VA decrease onset between 21 and 40 years of age. Forty-four patients in the first group noticed VF at an age between 21 and 30 years, and 74 patients between 11 and 30 years in the second group. Central scotoma was typical for the first group, and was detected in 115 patients. Concentric constriction was typical for the second group, and was found in 81 patients. Half of patients in both groups preserved best-corrected VA in the better eye at a level of 20/40 or better; 7% in the first group and 6% in the second group were registered as legally blind according to WHO criteria, having VA <1/50 or VF <5 degrees . Diagnosis frequency was USH I and II-34%, ST-31%, MD-18%, CHD-14%, BBD-5%.
CONCLUSIONS: An epidemiological approach to the estimation of the disease onset of various subtypes of monogenic retinal degenerations will be useful for detection of disease duration, its prognosis, rehabilitation and the researching of future treatment possibilities.

Entities:  

Mesh:

Year:  2009        PMID: 19277693     DOI: 10.1007/s00417-009-1059-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

Review 1.  Epidemiology of blindness and eye disease.

Authors:  H G Krumpaszky; V Klauss
Journal:  Ophthalmologica       Date:  1996       Impact factor: 3.250

Review 2.  Molecular genetics and prospects for therapy of the inherited retinal dystrophies.

Authors:  D A Bessant; R R Ali; S S Bhattacharya
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

Review 3.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

4.  Visual loss in retinitis pigmentosa.

Authors:  M F Marmor
Journal:  Am J Ophthalmol       Date:  1980-05       Impact factor: 5.258

5.  A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies.

Authors:  Saul Merin; Alexey Obolensky; Marilyn D Farber; Itay Chowers
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

6.  Prevalence and geographical distribution of Usher syndrome in Germany.

Authors:  Ulrich H M Spandau; Klaus Rohrschneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-05-23       Impact factor: 3.117

7.  Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway.

Authors:  J Grøndahl
Journal:  Clin Genet       Date:  1987-04       Impact factor: 4.438

Review 8.  [Hereditary retinochoroidal dystrophies. Part 1: Pathogenesis, diagnosis, therapy and patient counselling].

Authors:  U Kellner; H Tillack; A B Renner
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

9.  Blindness incidence in Germany. A population-based study from Württemberg-Hohenzollern.

Authors:  H G Krumpaszky; R Lüdtke; A Mickler; V Klauss; H K Selbmann
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

10.  Retinitis pigmentosa in Spain. The Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa.

Authors:  C Ayuso; B Garcia-Sandoval; C Najera; D Valverde; M Carballo; G Antiñolo
Journal:  Clin Genet       Date:  1995-09       Impact factor: 4.438

View more
  3 in total

1.  New Insights on the Regulatory Gene Network Disturbed in Central Areolar Choroidal Dystrophy-Beyond Classical Gene Candidates.

Authors:  João Paulo Kazmierczak de Camargo; Giovanna Nazaré de Barros Prezia; Naoye Shiokawa; Mario Teruo Sato; Roberto Rosati; Angelica Beate Winter Boldt
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

2.  The special electrophysiological signs of inherited retinal dystrophies.

Authors:  Elena Prokofyeva; Eric Troeger; Eberhart Zrenner
Journal:  Open Ophthalmol J       Date:  2012-10-31

3.  Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa.

Authors:  Hui Guo; Jisheng Li; Fei Gao; Jiangxia Li; Xinyi Wu; Qiji Liu
Journal:  BMC Ophthalmol       Date:  2015-07-28       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.